Global Consolidated Aesthetics, an aesthetic company, has raised $40M of financing from new investor OrbiMed, alongside nearly $20M from existing investors including Montreux Equity Partners and Oyster Capital.
In a release dated Feb. 21, the Company said this financing will fuel further international expansion, new product development and launches.
Ayse Kocak, CEO of GC Aesthetics, said: "We are delighted to have secured this funding that will allow GC Aesthetics consolidate its position as a market leader in aesthetics, and one which continues to keep women's interests at the forefront of all our goals. This has been an exciting year for us and we have laid the foundations to launch groundbreaking initiatives. This funding will enable us to maximise further growth, introduce our quality products to new markets and give patients and surgeons more choice than ever before."
Daniel Turner, Managing Director of Montreux Equity Partners and Chairman of GC Aesthetics, said, "Ayse and the GC Aesthetics management team are transforming the aesthetics market with their focus on the health and wellness of women. Our continued financial commitment demonstrates our excitement for GC Aesthetics growth prospects as it becomes a global market leader in aesthetics."
((Comments on this story may be sent to firstname.lastname@example.org))